Cover Image

31 High prevalence of CXCR4-using virus and low clonal expansion in infected naïve and central memory CD4+ T cells in individuals on ART

Saved in:

Bibliographic Details
Main Authors:	M. Roche (Author), C. Tumpach (Author), J. Symons (Author), P.U. Cameron (Author), M.J. Churchill (Author), S.G. Deeks (Author), P.R. Gorry (Author), S.R. Lewin (Author)
Format:	Book
Published:	Elsevier, 2017-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART
by: J. Symons, et al.
Published: (2019)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
by: Yi Shi, et al.
Published: (2020)

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
by: Zhang M, et al.
Published: (2022)

Natural scrub typhus antibody suppresses HIV CXCR4(X4) viruses
by: George Watt, et al.
Published: (2013)

CXCR4 in breast cancer: oncogenic role and therapeutic targeting
by: Xu C, et al.
Published: (2015)

The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
by: Jurgen Bernhagen
Published: (2016)

Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease
by: Hamid Mattoo, et al.
Published: (2017)

Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
by: Anthony Waked, et al.
Published: (2024)

An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
by: Wojciech G. Lesniak, et al.
Published: (2022)

Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions
by: Juan Xia, et al.
Published: (2012)

Restricted HIV-1 diversity and clonal expansion following cytoreductive chemotherapy
by: T.J. Henrich, et al.
Published: (2015)

Mesenchymal Stem Cells Attract Endothelial Progenitor Cells via a Positive Feedback Loop between CXCR2 and CXCR4
by: Yingyun Tan, et al.
Published: (2019)

Probing the Druggablility on the Interface of the Protein-Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimer
by: Liting Shen, et al.
Published: (2019)

IS4‐FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells
by: Isabel Hamshaw, et al.
Published: (2024)

The role of SDF-1/CXCR4 in the vasculogenesis and remodeling of cerebral arteriovenous malformation
by: Wang L, et al.
Published: (2015)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
by: Zhou X, et al.
Published: (2015)

The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?
by: Mitra Abbasifard, et al.
Published: (2024)

Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size
by: Isaline Renard, et al.
Published: (2024)

The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep
by: Anthony Russell V, et al.
Published: (2011)

Co-culture of T-cells with dendritic cells facilitates HIV latency in proliferating CD4+ T-cells: implications for the establishment and reversal of latency
by: N. Kumar, et al.
Published: (2015)

Establishment and maintenance of the human naïve CD4+ T-cell compartment
by: Susana L Silva, et al.
Published: (2016)

CXCR4 and RANK Combination as a Predictor of Breast Cancer Bone Metastasis in Indonesia
by: Erwin D Yulian, et al.
Published: (2021)

27 Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1
by: J. Bader, et al.
Published: (2016)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
by: Po-Yin Chu, et al.
Published: (2019)

An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation
by: Mirja Harms, et al.
Published: (2021)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
by: Naroa Serna, et al.
Published: (2021)

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
by: Kaat Luyten, et al.
Published: (2021)

Intact proviruses from naive and effector memory T-cells match persistent viremia
by: K. Fisher, et al.
Published: (2019)

Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study
by: Hussam Aly Sayed Murad, et al.
Published: (2022)

3 HIV-infected patients with exceptional TCD4+ recovery during effective HAART present a distinct T CD4+ differentiation pattern, higher CD31neg naïve cells and a smaller HIV reservoir
by: L. Leon-Fuentes, et al.
Published: (2016)

Review of Studies of Educational Evaluation, Volume 31(4)
by: Otto W. Gustafson
Published: (2006)

CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis
by: Kozlowski Joseph, et al.
Published: (2009)

Discovery of dibenzyl amide derivatives as novel CXCR4 modulators against inflammatory bowel disease
by: Xiaoying Jiang, et al.
Published: (2024)

Retraction Note: RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells
by: Tao Wang, et al.
Published: (2019)

Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7
by: Jiayi Zheng, et al.
Published: (2018)

CCR5- and CXCR4-tropic HIVs infect CD4+ hematopoietic stem and progenitor cells in vitro and in optimally treated people
by: N. Sebastian, et al.
Published: (2015)

No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV infected patients receiving suppressive maraviroc therapy
by: J. Izopet, et al.
Published: (2015)

PP 4.16 - 00188 Investigating the Role of Naïve CD4+ T-cells as a CTL Resistant Sanctuary for Intact HIV Proviruses
by: J. Weiler, et al.
Published: (2022)

Deletion of Wild-type p53 Facilitates Bone Metastatic Function by Blocking the AIP4 Mediated Ligand-Induced Degradation of CXCR4
by: Qiji Li, et al.
Published: (2022)

An agonist of the CXCR4 receptor accelerates the recovery from the peripheral neuroparalysis induced by Taipan snake envenomation.
by: Marco Stazi, et al.
Published: (2020)